1. Japan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Koken Ltd.

Koken Ltd.

TTSE:7963
1,723.00
JPY
-10.00
(-0.58%)
8.29BMarket Cap
Nov 06Next Earn
Koken Ltd.
TSE:7963
(Tokyo Stock Exchange)

Recent

price

1,723.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
JPY
1,455.03
1,755.67
1,646.21
1,481.49
1,482.91
1,534.33
1,579.37
1,686.78
1,660.19
1,718.54
2,028.02
2,038.26
2,136.43
2,142.59
2,176.92
2,408.46
- -
Revenue per Share
83.31
109.46
76.07
45.45
29.22
46.84
77.23
98.19
71.55
74.21
167.34
172.27
167.85
141.89
146.05
179.82
- -
Basic EPS, GAAP
164.53
0.51
103.23
70.24
12.19
-112.17
105.9
-49.43
-396.47
300.15
141.75
83.36
91.01
179.5
90.09
-47.16
- -
Free Cash Flow per Basic Share
24.89
24.98
34.89
25.11
24.95
24.92
25.2
25.15
30.08
25.26
25.04
45.24
35.63
45.63
35.32
36.04
- -
Dividend per Share
1,585.68
1,674.04
1,705.84
1,719.1
1,731.71
1,751.57
1,795.48
1,879.87
1,911.51
1,956.95
2,090.67
2,220.01
2,392.01
2,499.09
2,635.81
2,805.84
2,845.17
Book Value per Share
1,579.85
1,667.42
1,697.81
1,703.38
1,712.79
1,734.44
1,781.34
1,867.81
1,899.71
1,948.03
2,079.81
2,208.84
2,380.6
2,489.26
2,624.43
2,792.79
2,831.99
Tangible Book Value per Share
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
Basic Weighted Avg Shares
7,359
8,879
8,330
7,476
7,501
7,786
7,937
8,460
8,327
8,605
10,152
10,203
10,604
10,587
10,762
11,857
- -
Sales/Revenue/Turnover
11.19
16.19
11.81
9.01
4.94
6.76
7.99
8.58
5.61
6.6
11.16
9.27
11.17
9.52
9.38
10.72
- -
Operating Margin (%)
536
527
577
561
505
469
436
425
461
588
596
666
594
490
441
417
- -
Depreciation Expense
421
554
385
229
148
238
388
492
359
372
838
862
833
701
722
885
- -
Net Income, GAAP
42.71
45.33
43.6
43.84
52.67
47.1
30.04
25.63
24.78
27.94
20.17
26.71
28.18
28.38
28
27.48
- -
Effective Tax Rate (%)
5.73
6.23
4.62
3.07
1.97
3.05
4.89
5.82
4.31
4.32
8.25
8.45
7.86
6.62
6.71
7.47
- -
Profit Margin (%)
1,328
1,812
2,684
2,419
3,078
3,116
3,378
3,373
2,724
1,861
2,535
3,881
4,839
5,456
5,890
6,325
6,658
Working Capital
1,950
2,188
2,280
2,217
2,594
3,224
3,168
3,489
4,844
3,240
3,366
3,493
3,435
3,178
2,697
2,432
2,708
LT Debt
8,020
8,466
8,647
8,679
8,775
8,891
9,004
9,428
9,587
9,796
10,466
11,113
11,819
12,352
13,036
13,797
13,767
Total Equity
2.51
4.43
2.89
1.82
1.23
1.91
2.97
3.54
2.14
2.44
5.48
4.07
4.78
3.93
3.94
4.82
- -
Return on Invested Capital (%)
3.29
4.2
2.96
1.85
1.24
1.84
2.85
3.45
2.4
2.44
5.35
5.3
4.91
4.04
4.13
4.91
- -
Return on Capital (%)
5.35
6.72
4.5
2.65
1.69
2.69
4.34
5.34
3.77
3.83
8.27
7.99
7.27
5.8
5.69
6.6
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
ST Debt
2,234
- -
2,759
LT Borrowings
3,378
- -
2,700
LT Finance Leases
- -
- -
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
8,156
9,290
8,289

Working Capital

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
Total Current Assets
9,341
- -
10,723
Cash, Cash Equivalents & STI
2,697
- -
2,840
Accounts Receivable, Net
1,935
- -
1,548
Inventories
2,574
- -
3,567
Total Current Liabilities
3,352
- -
4,065
Payables & Accruals
- -
- -
- -
ST Debt
2,234
- -
2,759
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.51%
5.68%
5.84%
Free Cash Flow
-0.48%
-27.7%
-152.13%
Net Income, GAAP
20.13%
1.86%
22.61%
Sales/Revenue/Turnover
4.44%
3.22%
10.17%
Total Cash Common Dividend
6.76%
13.07%
1.61%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,427
2,367
- -
- -
10,762
2025
- -
- -
- -
- -
11,857
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
31.68
16.61
- -
- -
146.05
2025
- -
- -
- -
- -
179.82
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
35.32
2025
- -
- -
- -
- -
36.04
2026
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Koken Ltd. (7963.T) manufactures and sells occupational personal protective equipment and environmental quality improvement systems in Japan. The company operates through Mask-Related Business, Environmental-Related Businesses, and Other Businesses segments; its core products include respirators for industrial use such as particulate respirators, powered air-purifying respirators, supplied air respirators, chemical cartridge respirators, and gas masks; respirators and masks for medical facilities and general consumers; clean air solutions comprising the KOACH super clean zone creator, KOKENLAMINAR push-pull ventilation system, and LAMIKOACH air ventilation system; health solutions featuring the IMADEZE copper-based lactate antibacterial agent and functional water production systems including electrolyzed water generators, endoscope washers/disinfectors such as Kagami-Naishi II G, blood stain washer kits, and portable showers; as well as equipment for accident and disaster countermeasures, protective clothes, ear plugs, and face shields. Founded in 1943 and headquartered in Chiyoda-ku, Tokyo, Koken Ltd. maintains manufacturing facilities across Japan including Techno-Yards in Saitama, Gunma, and Kanagawa prefectures, with a consolidated workforce of 321 employees and an overseas subsidiary, SIAM KOKEN LTD., in Thailand. Recent developments include the opening of the KOACH Kumamoto showroom in September 2023 to support sales growth in the Kyushu semiconductor hub; initiation of overseas expansion with KOACH system deployment at Stanford University's semiconductor laboratory in the United States as of fiscal year 2024 forecasts; projected 65.3% year-on-year revenue increase to 1.6 billion yen in the environmental-related business driven by semiconductor market recovery and strengthened marketing; and sustained expansion of the health business segment with 15.8% sales growth to 400 million yen anticipated from endoscope washer/disinfectors.